Drug
Csl787
Csl787: highest development phase Phase 2, developed by CSL. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- CSL
Trials
| Drug | Phase | Indication |
|---|---|---|
| CSL787 NCT07048262 | Phase 2 | Non-cystic Fibrosis Bronchiectasis |
Latest
No recent events.
Follow Csl787 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.